The current drugs for the treatment of osteoporosis include bisphosphonates, estrogen, receptor activator of nuclear factor kappa B ligand (RANKL) inhibitors, etc. These drugs play important roles clinically, but their serious side effects limit their clinical use [5, 6]. Here, TNFSF11 is linked to osteoporosis.